Clinical Trial

The Impact of PRISCUS Medication on Fall Risks

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Purpose: This study aims to validate the medication entries in the PRISCUS list-a German expert-based compilation of potentially inappropriate medications for older adults-and to identify additional medications that may pose a fall risk but are not yet included. Study Design: This is a retrospective observational study uses electronic health record data from a German research hospital. It includes over 900,000 patient records from multiple departments with a high incidence of falls, covering the period from 2016 to 2022. Statistical analyses, including chi-square tests and propensity score matching, will be employed to evaluate the relationship between medications and fall events.
Trial Details
NCT Number NCT07181993
Lead Sponsor Charite University, Berlin, Germany
Conditions Fall Injury
Enrollment 932,912 participants
Start Date 2024-09-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-19